The interest in biomarker research has been growing exponentially, and this trend is not expected to reverse soon. Although the clinical usefulness of laboratory tests is conventionally defined in terms of diagnostic efficiency or clinical efficacy (or effectiveness), these notions are complementary but not interchangeable.
An adequate evaluation of the prognosis in patients with pulmonary embolism may guide decision-making in terms of the intensity of the initial treatment during the acute phase, duration of treatment, and intensity of follow-up control visits in the long term.
The review emphasizes the importance of strategies to reduce bleeding in the modern era, discusses the role of non-vitamin K oral anticoagulants, and reviews recent recommendations, ongoing clinical trials, and future directions.
The first part of the review discusses prerequisites for antithrombotic management in patients with atrial fibrillation undergoing percutaneous coronary intervention.
A review discussing the strengths, challenges, and usefulness of network meta-analyses in clinical practice.
English
Polski
Español
українська